Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 13/20 | 1.00 |
| ▸ | GLRB | P48167 | 13/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | TAS2R10 | Q9NYW0 | 2/20 | 1.00 |
| ▸ | SCN1A | P35498 | 1/20 | 1.00 |
| ▸ | TAS2R46 | P59540 | 1/20 | 1.00 |
| ▸ | SCN2A | Q99250 | 1/20 | 1.00 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Strychnine SCHEMBL14047653 | 1.00 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL21985190 | 1.00 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL29352583 | 1.00 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL29362678 | 1.00 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL12549549 | 1.00 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL14029424 | 1.00 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL14117483 | 1.00 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL25300604 | 0.99 | GLRA1 (0.98) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL31047368 | 0.99 | GLRA1 (0.98) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL184168 | 0.99 | GLRA1 (0.98) | GLRA1GLRBCYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14353 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137082-A1 | FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL | SYNGENTA CROP PROTECTION AG (CH) | 2026-05-21 | — | — | US | claimed |
| EP-2991482-B1 | PACKAGED RODENTICIDAL BAIT | BASF AGRO BV (NL) | 2026-05-20 | — | — | EP | claimed |
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| EP-3578542-B1 | COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-11-12 | — | — | EP | claimed |
| EP-3578543-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-08-20 | — | — | EP | claimed |
| CN-120064532-A | Detection method and application of jade leaf detoxification granules | 三金集团湖南三金制药有限责任公司 | 2025-05-30 | — | — | CN | claimed |
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | claimed |
| CN-116672353-B | Traditional Chinese medicine composition for enhancing phagocytic capacity of macrophages and preparation method thereof | 浙江大学智能创新药物研究院 | 2025-05-16 | — | — | CN | claimed |
| US-12279613-B2 | Attractant blend compositions, devices and methods for attracting female mice | VARNER ELANA (US) | 2025-04-22 | — | — | US | claimed |
| CN-119345263-B | A Chinese medicinal composition for treating rheumatoid diseases composition for treating osteoarthritis | 津药达仁堂集团股份有限公司中药研究院 | 2025-04-18 | — | — | CN | claimed |
| US-4841668-A | Gopher killer | MCKENZIE CARL O (US) | 1989-06-27 | — | — | US | claimed |
| WO-1989005301-A1 | USE OF COMPOUNDS OF THE RETULINE SERIES AS COMPOUNDS WITH PHARMACEUTICAL ACTIVITY, IN PARTICULAR ANALGESIC, ANTISPASMODIC AND ANTIINFLAMMATORY MEDICAMENTS | UNIVERSITE DE LIEGE (BE) | 1989-06-15 | — | — | WO | claimed |
| EP-0273349-A2 | Resolution of 1,4-dihydropyridine derivatives | LABORATOIRES SYNTEX S.A. (FR) | 1988-07-06 | — | — | EP | claimed |
| US-4746616-A | DETECTION OF TAMPERING | THE BOARD OF REGENTS OF THE UNIVERSITY OF WASHINGTON (US) | 1988-05-24 | — | — | US | claimed |
| EP-0249245-A2 | Antihypertensive dihydropyridine derivatives | LABORATOIRES SYNTEX S.A. (FR) | 1987-12-16 | — | — | EP | claimed |
| EP-0128684-A1 | Process for producing 3-(3,4-dihydroxyphenyl) serine | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1984-12-19 | — | — | EP | claimed |
| EP-0117080-A2 | Skin treatment composition | UNILEVER PLC (GB) | 1984-08-29 | — | — | EP | claimed |
| US-4224457-A | Process for manufacturing optically active sulfur-containing carboxylic acid | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1980-09-23 | — | — | US | claimed |
| US-4048224-A | Process for resolving alanine, 3-fluoro and 2-deutero-3-fluoro-DL-alanine | MERCK & CO., INC. (US) | 1977-09-13 | — | — | US | claimed |
| US-4042698-A | Treatment of myasthenia gravis and oral medication therefor | ZAPPIA JOSEPH FRANCIS | 1977-08-16 | — | — | US | claimed |